Post-Approved Phase III Study of 1-LV/5FU [leucovorin/fluorouracil] Therapy.
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2009
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 Oct 2009 Primary endpoint 'Overall Survival duration' has been met.
- 12 Oct 2009 Results have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
- 18 Aug 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History